Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
elevationpharma.com

See what CB Insights has to offer

Total Raised

$60.24M

Investors Count

7

Deal Terms

3

Elevation Pharmaceuticals Funding, Elevation Pharmaceuticals Valuation & Elevation Pharmaceuticals Revenue

4 Fundings

Elevation Pharmaceuticals's latest funding round was a Acquired for on August 17, 2012.

Elevation Pharmaceuticals's valuation in January 2010 was $77.96M.

Elevation Pharmaceuticals's latest post-money valuation is from August 2012.

Sign up for a free trial to see Elevation Pharmaceuticals's valuations in August 2012 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/17/2012

Acquired

$99M

3

12/16/2011

Series B

$99M

10

1/21/2010

Series A

$99M

$77.96M

0

4/13/2009

Grant

$99M

0

Date

8/17/2012

12/16/2011

1/21/2010

4/13/2009

Round

Acquired

Series B

Series A

Grant

Amount

$99M

$99M

$99M

Investors

Valuation

$99M

$77.96M

Revenue

Sources

3

10

0

0

Elevation Pharmaceuticals Deal Terms

3 Deal Terms

Elevation Pharmaceuticals's deal structure is available for 3 funding rounds, including their Acquired from August 17, 2012.

Round

Acquired

Series B

Series A

Funding Date

$99M

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

$99M

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

Elevation Pharmaceuticals Investors

7 Investors

Elevation Pharmaceuticals has 7 investors. Sunovion invested in Elevation Pharmaceuticals's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

8/17/2012

8/17/2012

1
Acquired

Corporation

Massachusetts

00/00/0000

00/00/0000

Canaan Partners

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Care Capital

Subscribe to see more

Subscribe to see more

Venture Capital

New Jersey

00/00/0000

00/00/0000

Mesa Verde Venture Partners

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

TPG Biotech

Subscribe to see more

Venture Capital

California

First funding

8/17/2012

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

8/17/2012

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Canaan Partners

Care Capital

Mesa Verde Venture Partners

TPG Biotech

Rounds

1
Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Corporation

Venture Capital

Venture Capital

Venture Capital

Venture Capital

Location

Massachusetts

California

New Jersey

California

California

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.